Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,873) with videos related to
Page
of 188
Sort By:
Journal of the American Heart Association
|
October 29, 2021
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study
Wendy Wang, Faye L Norby, Michael J Zhang, et al.
Nature Medicine
|
May 6, 2024
A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials
Toru Kondo, Pardeep S Jhund, Samvel B Gasparyan, et al.
European Heart Journal
|
May 26, 2011
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial
Anne-Catherine Pouleur, Dorit Knappe, Amil M Shah, et al.
European Journal of Heart Failure
|
October 23, 2010
The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction
Amil M Shah, Hajime Uno, Lars Køber, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 25, 2007
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy
Gary F Mitchell, Mark E Dunlap, Wayne Warnica, et al.
Journal of the American College of Cardiology
|
July 16, 2013
Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity)
Chih M Wong, Nathaniel M Hawkins, Pardeep S Jhund, et al.
Circulation. Heart Failure
|
April 13, 2018
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure)
Orly Vardeny, Brian Claggett, Jessica Kachadourian, et al.
JACC. Heart Failure
|
February 10, 2020
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF
John R Teerlink, Rafael Diaz, G Michael Felker, et al.
Congestive Heart Failure (Greenwich, Conn.)
|
August 4, 2007
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction
Lisa M Mielniczuk, Gervasio A Lamas, Greg C Flaker, et al.
Journal of the American Heart Association
|
November 27, 2019
Association of Left Atrial Enlargement and Atrial Fibrillation With Cognitive Function and Decline: The ARIC-NCS
Michael J Zhang, Faye L Norby, Pamela L Lutsey, et al.
Page
of 188
Search research articles
Search
Showing results (991-1000 of 1,873) with videos related to
Sort By:
Page
of 188
Journal of the American Heart Association
|
October 29, 2021
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study
Wendy Wang, Faye L Norby, Michael J Zhang, et al.
Nature Medicine
|
May 6, 2024
A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials
Toru Kondo, Pardeep S Jhund, Samvel B Gasparyan, et al.
European Heart Journal
|
May 26, 2011
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial
Anne-Catherine Pouleur, Dorit Knappe, Amil M Shah, et al.
European Journal of Heart Failure
|
October 23, 2010
The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction
Amil M Shah, Hajime Uno, Lars Køber, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 25, 2007
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy
Gary F Mitchell, Mark E Dunlap, Wayne Warnica, et al.
Journal of the American College of Cardiology
|
July 16, 2013
Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity)
Chih M Wong, Nathaniel M Hawkins, Pardeep S Jhund, et al.
Circulation. Heart Failure
|
April 13, 2018
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure)
Orly Vardeny, Brian Claggett, Jessica Kachadourian, et al.
JACC. Heart Failure
|
February 10, 2020
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF
John R Teerlink, Rafael Diaz, G Michael Felker, et al.
Congestive Heart Failure (Greenwich, Conn.)
|
August 4, 2007
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction
Lisa M Mielniczuk, Gervasio A Lamas, Greg C Flaker, et al.
Journal of the American Heart Association
|
November 27, 2019
Association of Left Atrial Enlargement and Atrial Fibrillation With Cognitive Function and Decline: The ARIC-NCS
Michael J Zhang, Faye L Norby, Pamela L Lutsey, et al.
Page
of 188